AI Article Synopsis
Article Abstract
Background/aim: The purpose of the present study was to evaluate the Turkish reliability and validity of the medical outcomes study (MOS) sleep scale in patients who have obstructive sleep apnea.
Materials And Methods: The data of the study were collected from 120 adult patients with obstructive sleep apnea and from 90 healthy individuals between March 04 and May 31, 2019.
Results: The Cronbach’s α internal consistency reliability coefficient of the MOS sleep scale was found as 0.82. The test-retest reliability was acceptable (r = 0.76-0.94). Six factors were identified by the factor analysis. These were the same as those in the original MOS-Sleep. The correlations between the MOS-Sleep and other instruments administered in this study provided evidence for structural validity. A significant relation was determined between MOS sleep scale and obstructive sleep apnea syndrome (OSAS) severity and the healthy group ( P < 0.05). In addition, the Cronbach α internal consistency reliability coefficient of the healthy group in MOS sleep scale was found as 0.78. The items of the six factors that were obtained with the confirmatory factor analysis for the MOS sleep scale of the healthy group were found to be the same as in the original MOS-Sleep.
Conclusion: Turkish MOS sleep scale is a measurement tool that consists of 12 items and 6 subdimensions with adequate validity and reliability indicators.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991870 | PMC |
| http://dx.doi.org/10.3906/sag-1909-157 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and Safety of Juan Bi Pill with Add-on Methotrexate in Active Rheumatoid Arthritis: A 48-Week, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.
Chin J Integr Med
December 2024
Spine Institute, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Objective: To explore the efficacy and safety of Juan Bi Pill (JBP) in treatment of active rheumatoid arthritis (RA).
Methods: From February 2017 to May 2018, 115 participants from 4 centers were randomly divided into JBP group (57 cases) and placebo group (58 cases) in a 1:1 ratio using a random number table method. Participants received a dose of JBP (4 g, twice a day, orally) combined with methotrexate (MTX, 10 mg per week) or placebo (4 g, twice a day, orally) combined with MTX for 12 weeks.
Psychiatric comorbidities of attention deficit/hyperactivity disorder in Japan: a nationwide population-based study.
Front Psychiatry
October 2024
Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Introduction: This study aimed to estimate prevalence and incidence of attention deficit/hyperactivity disorder (ADHD) and comorbid relationships between ADHD and other psychiatric disorders in Japan.
Methods: Using the real-world JMDC Claims Database, we conducted a cross-sectional study (analysis years 2017-2021) and retrospective cohort study (observation 2 years before/after the initial ADHD diagnosis; data collection 2005-2021; enrollment 2017-2019). Patients were male or female, aged 0-57 years.
The Self-Reported Quality of Sleep and Its Relationship with the Development of Arterial Hypertension: Perspectives from the Tlalpan 2020 Cohort.
J Clin Med
October 2024
Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Tlapan, Mexico City 14080, Mexico.
A well-established association exists between the development of hypertension and sleep quality. The connection between self-reported sleep quality and the onset of hypertension is particularly significant in populations with metabolic deterioration, such as in Mexico. The Tlalpan 2020 Cohort was analyzed to explore this association.
View Article and Find Full Text PDFA case series: Three cases of Morvan's syndrome as a rare autoimmune disorder with anti-Caspr2 antibody.
Medicine (Baltimore)
October 2024
Clinical Department of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Article Synopsis
- Morvan syndrome is a rare autoimmune disorder primarily affecting males, characterized by symptoms like muscle twitching, autonomic disturbances, and severe sleep issues, often linked to specific autoantibodies.
- Current treatments include various immunotherapies, but no long-term cure exists, prompting interest in alternative therapies like traditional Chinese medicine.
- Three patients with serum Caspr2-positive Morvan syndrome showed some relief from traditional treatments but experienced disease recurrence, indicating the complexity and unpredictability of the condition.
Effects of transcranial magnetic stimulation on sleep quality in fibromyalgia: A double-blind randomized clinical trial.
Sleep Med
December 2024
Department of Neurology and Psychiatry Department, Faculty of Medicine, Assiut University, Egypt. Electronic address:
Article Synopsis
- The study aimed to see if a treatment called rTMS could help people with fibromyalgia sleep better.
- It involved 42 patients who either got the real treatment or a fake one, going through 20 sessions.
- Results showed that those who received the real rTMS treatment had much better sleep quality after 1 and 3 months compared to those who didn't.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!